Search

everythinglearnresearchcommunity

for

Search:↓

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Erdr1 could be a new marker for diagnosing hair loss.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Adult fibroblasts help heart cells mature and improve heart function.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

Skin cell-derived vesicles can help heal skin injuries effectively.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.